A safer, non-explosive class of sulfur-based reagents for electrophilic alkynylation and cyanation. These 5-(alkynyl)dibenzothiophenium triflate reagents provide a high-yield, stable, and chemically selective alternative to traditional, hazardous EBX reagents. Suitable for industrial, pharmaceutical, and agricultural applications requiring precise C-C or C-N bond formation.
This technology introduces a new class of sulfur-based reagents, 5-(alkynyl)dibenzothiophenium triflates, designed for the electrophilic alkynylation and cyanation of organic molecules. Utilizing the structural backbone of the Umemoto reagent, these compounds address a critical safety limitation in chemical synthesis. Unlike widely used ethynylbenziodoxolone (EBX) reagents, which are potentially explosive, these novel reagents are non-explosive, air-stable, and offer high performance, making them a superior alternative for industrial and academic chemical synthesis.
The technology is currently at TRL 3. The superior chemical properties and performance of the lead compounds have been experimentally validated at the laboratory scale, and intellectual property protection is established through a granted US patent and a filed German patent application. Further development is required to scale for commercial industrial application.
Georg‑August‑Universität Göttingen is a comprehensive public research university in Lower Saxony with broad academic breadth and a major university medical center. Through the Göttingen Campus alliance, the university is co‑located with Max Planck and Leibniz institutes, supported by a shared research data center that links campus partners and services. Clinical translation is enabled by the University Medical Center Göttingen, while proximity to leading life‑science and precision‑measurement companies in the region supports applied collaboration and talent pipelines. The university’s research is supported by competitive funding from the German Research Foundation, federal ministries, and European programmes. Technology transfer is provided by MBM ScienceBridge, a wholly owned subsidiary that manages IP, licensing, and startup support.